A Safety Follow-up Study of a Phase 2 Clinical Trial Evaluating the Efficacy and Safety of Cellgram-ED (Autologous Bone Marrow-Derived Mesenchymal Stem Cells) in Patients With Post-Radical Prostatectomy Erectile Dysfunction
Latest Information Update: 03 Mar 2026
At a glance
- Drugs Autologous mesenchymal stem cell therapy Pharmicell (Primary)
- Indications Erectile dysfunction
- Focus Adverse reactions
- Acronyms Cellgram-ED
- Sponsors Pharmicell
Most Recent Events
- 03 Mar 2026 New trial record